Experience and complications with the use of hypertonic intra-amniotic saline solution.
D000032:Abortion, Therapeutic / Q000009:adverse effects; D000293:Adolescent; D000328:Adult; D000347:Afibrinogenemia / Q000209:etiology; D000653:Amniotic Fluid / Q000032:analysis; D002584:Cervix Uteri; D003475:Curettage; D004716:Endometritis / Q000209:etiology; D005260:Female; D005865:Gestational Age; D006801:Humans; D006982:Hypertonic Solutions; D008423:Maternal Age; D008722:Methods; D010298:Parity; D006473:Postpartum Hemorrhage / Q000209:etiology; D011247:Pregnancy; D012965:Sodium Chloride / Q000627:therapeutic use*; D014597:Uterine Rupture / Q000209:etiology; D014839:Vomiting / Q000209:etiology
D006982:Hypertonic Solutions; D012965:Sodium Chloride